diphenyl has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Balaji, KC; Chalfant, V; Chauhan, J; Fletcher, S; Krishnan, S; Mackeyev, Y; Osumi, T; Riveros, C; Shukla, S; Singh, PK | 1 |
| Kanamori, T; Katou, M; Kuwabara, S; Ogura, SI; Ohtani, H; Okazaki, S; Tsuga, Y; Yuasa, H | 1 |
| Hartmann, RW; Hu, Q; Negri, M; Olgen, S | 1 |
3 other study(ies) available for diphenyl and Prostatic Neoplasms
| Article | Year |
|---|---|
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth.
Topics: Animals; Carboxylic Acids; Dimerization; Humans; Male; Mice; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Transcription Factors | 2022 |
A Twist-Assisted Biphenyl Photosensitizer Passable Through Glucose Channel.
Topics: Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Glucose; Humans; Infrared Rays; Male; Molecular Structure; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Quantum Theory; Structure-Activity Relationship | 2019 |
The role of fluorine substitution in biphenyl methylene imidazole-type CYP17 inhibitors for the treatment of prostate carcinoma.
Topics: Animals; Antineoplastic Agents; Binding Sites; Biphenyl Compounds; Carcinoma; Computer Simulation; Drug Design; Fluorine; Humans; Imidazoles; Male; Prostatic Neoplasms; Protein Structure, Tertiary; Rats; Rats, Wistar; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship | 2010 |